MedTrace Logo

Hämeenlinna Metabolic Syndrome Research Program: Oxidized LDL and Arterial Elasticity in Metabolic Syndrome and Controls (HMS-01)

NCT01114763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2010-05-04

No results posted yet for this study

Summary

Mechanisms that link metabolic syndrome to atherosclerosis are incompletely understood. As a part of Hämeenlinna Metabolic Syndrome Research Program (HMS), 40 men with metabolic syndrome and their 40 physically active controls (age: 30 to 65 years) are compared in a cross-sectional study. Except routine laboratory parameters, arterial elasticity and levels of oxidized LDL are determined.

Study hypothesis: Levels of oxidized LDL and findings in arterial elasticity may differ between subjects with metabolic syndrome and controls explaining the elevated risk for cardiovascular diseases among patients with metabolic syndrome.

Conditions

  • Metabolic Syndrome

Sponsors & Collaborators

  • Linnan Klinikka Oy

    collaborator OTHER

  • Kanta-Häme Central Hospital

    lead OTHER_GOV

Principal Investigators

  • Ari K Palomäki, MD PhD · Central Hospital of Kanta-Häme

  • Kalevi Oksanen, MD PhD · Central Hospital of Kanta-Häme

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2005-11-30
Completion
2007-09-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01114763 on ClinicalTrials.gov